AssayIndex

BCH-2506-L7534

GHRP-2 · 2 mg declared · Bachem Holding (Suzhou) Co., Ltd. · manufactured 08 Jun 2025

CHARACTERISED
Lot code
BCH-2506-L7534
Supplier
BCH — Bachem Holding (Suzhou) Co., Ltd.
Compound
GHRP-2
Compound class
Growth-hormone axis peptides
Declared label claim
2mg
Manufacture date
08 Jun 2025
Index quarter
2025-Q3
Independent assays
10
Laboratories involved
Janoshik, Nordanalyt, PeptideMeter
Provenance mix
Supplier-supplied ×9 · Laboratory-retained ×1
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 10
Median purity 98.63% n=10
Spread (max − min) 1.25pp n=10
Standard deviation 0.393pp n=10
97.798.198.598.999.399.7100.1This lot (BCH-2506-L7534)This lot (BCH-2506-L7534): Q1 98.41, median 98.63, Q3 98.69, n=10outlier 97.91outlier 99.16n=10All GHRP-2All GHRP-2: Q1 98.93, median 99.22, Q3 99.58, n=97outlier 97.91n=97 Purity (% area)
Figure 1. This lot's independent purity results against the whole GHRP-2 record set in the index. The vertical line is the index acceptance specification for the growth-hormone axis peptides class, 99.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 10

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-021309BCH-2506-L7534Janoshik2025-Q398.578.5697.2Supplier-supplied2FAIL
AX-2025-021310BCH-2506-L7534Janoshik2025-Q398.698.4995.5Supplier-supplied3FAIL
AX-2025-021311BCH-2506-L7534Janoshik2025-Q397.917.9890.8Laboratory-retained2FAIL
AX-2025-021312BCH-2506-L7534Janoshik2025-Q398.048.61103.4Supplier-supplied2FAIL
AX-2025-021313BCH-2506-L7534Janoshik2025-Q398.698.40Supplier-supplied2FAIL
AX-2025-021314BCH-2506-L7534Janoshik2025-Q399.067.70Supplier-supplied2MARGINAL
AX-2025-021315BCH-2506-L7534Nordanalyt2025-Q399.168.23Supplier-supplied2MARGINAL
AX-2025-021316BCH-2506-L7534Janoshik2025-Q398.387.8690.6Supplier-supplied2FAIL
AX-2025-021317BCH-2506-L7534PeptideMeter2025-Q398.698.2592.0Supplier-supplied2FAIL
AX-2025-021318BCH-2506-L7534Janoshik2025-Q398.518.95Supplier-supplied2FAIL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Janoshik898.57, 98.69, 97.91, 98.04, 98.69, 99.06, 98.38, 98.5198.5430min+0.0098.54
Nordanalyt199.1699.1635min+0.0299.14
PeptideMeter198.6998.6928min-0.0598.74

This lot contributes 3 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)98.598.57divergence -0.13 pp vs batch median
Total impurities (% area)1.501.43
Largest single impurity (% area)0.590.96
Water (%)7.28.56
Counter-ion (%)not stated6.21
Peptide content (%w/w)not stated84.63
Endotoxin (EU/mg)not statednot determined
Method stated on certificateYEScolumn, gradient and wavelength given
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
oxidised Trp (+16 Da)10 / 100.900.56–1.40
[D-2-Nal]-epimer10 / 100.180.09–0.47
des-Lys (−128 Da)10 / 100.150.05–0.40
C-terminal free acid (+1 Da)10 / 100.090.04–0.16
Section 7

What this rollup does not establish